if you want to buy apple account, choose buyappleacc.com, buyappleacc.com is a best provider within bussiness for more than 3 years. choose us, you will never regret. we provied worldwide apple developer account for sale.
TODAY, we will no longer be able to hear the soothing voice of Siti Sarah who succumbed to Covid-19. This tragic incident is not an isolated incident. Siti, just like other pregnant women who passed away from Covid-19, was not vaccinated against the virus.
This leads us to the serious question of what this country’s policy is regarding the administration of the Covid-19 vaccine for pregnant women in Malaysia.
There are a number of concerns that need to be urgently addressed. If further ignored, it will lead to many more unnecessary Covid-19-related deaths among pregnant women.
The 2nd edition of the Clinical Guideline for Covid-19 in Malaysia that was published on the on 13th April 2021 mentions in page 69 that a pregnant mother can be vaccinated between 14 to 33 weeks of gestation.
It further states that the second dose of vaccine should be deferred until 14 weeks of gestation if the woman finds out that she is pregnant after receiving her first jab.
It took 2 months for the committee to improve the guidelines and come up with the 3rd edition, which was published on 12th July 2021.
However, despite the increasing deaths among pregnant mothers caused by Covid-19, the following sentence still remains at page 110 of the report: “First dose of the vaccine is to be administered between 14-33 weeks of pregnancy”.
The committee, also represented by six obstetrics and gynaecology (O&G) specialists, continue to ignore the guidelines applied in other countries.
The Royal College of Obstetricians and Gynaecologists in United Kingdom has stated that the Covid-19 vaccine is considered to be “safe and effective at any stage of pregnancy”.
Even The Royal Australian and New Zealand College of Obstetricians and Gynaecologists and the Australian Technical Advisory Group on Immunisation, has explicitly mentioned that pregnant women should be routinely offered the vaccine at any stage of pregnancy.
“Pregnancy outcomes following mRNA vaccination (Pfizer-BioNTech and Moderna) appear similar to comparator groups prior to the onset of Covid-19… The most common adverse outcomes among 724 livebirths in the study by Shimabukuro et al.11 (June 17, 2021) were preterm birth (9.4%), small-for-gestational-age (3.2%) and major congenital anomalies (2.2%) – all consistent with published rates. None of the mothers whose babies were born with congenital anomalies.”
Therefore, where was the “window period of 14-33 weeks” relied on by Malaysian health authorities extrapolated from? If there is no strong basis for this, we urgently call upon the committee to remove this from the guideline.
This deadly sentence creates fear among pregnant women which may deter them from receiving their vaccination, especially those above 33 weeks of pregnancy.
Another issue that also needs to be addressed there are not enough government clinics nationwide that offer vaccinations to pregnant mother. Therefore, we demand clear, simple, and straightforward guidelines as these guidelines are they are relied on by government clinics, staff nurses, vaccination providers, and O&G specialists nationwide.